Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis

• Status: Completed
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Miltefosine (longer course) will be used to try to improve the cure rate of mucosal leishmaniasis

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AB Foundation
• Treatments: Miltefosine

Criteria

Inclusion Criteria:

• Mucosal leishmaniasis

Exclusion Criteria:

• No comcomitant disease as judged by laboratory and clinical parameters